期刊文献+

低氧诱导因子抑制剂对白血病细胞株HIF-1α和VEGF表达及诱导细胞凋亡作用的研究 被引量:5

Effects of Hypoxia-Inducible Factor Inhibitor on Expression of HIF-1α and VEGF and Induction of Apoptosis in Leukemic Cell Lines
下载PDF
导出
摘要 本研究探讨低氧诱导因子抑制剂3-(5′-hydroxymethyl-2′-furyl)-1-benzylindazole(YC-1)对人急性白血病病细胞低氧诱导因子1α(hypoxia inducible factor1α,HIF-1α)和血管内皮因子(vascular endothelial growth factor,VEGF)的调节及诱导细胞凋亡作用。应用DAPI染色检查凋亡细胞的形态;流式细胞术检测细胞凋亡率;RT-PCR检测K562、U937、Jurkat白血病细胞株hif-1α和vegf mRNA表达以及YC-1对U937细胞hif-1α、vegf mRNA表达影响;Western blot检测YC-1对U937细胞HIF-1α和VEGF蛋白表达,以及BAX、BCL-2、caspase-3蛋白变化,分析YC-1诱导U937细胞凋亡的可能机制。结果表明:在3种白血病细胞株均可见hif-1α和vegf mRNA表达。4μmol/L YC-1处理U937细胞(0、8、16和24小时)后,可见凋亡细胞出现的典型凋亡形态特征;流式细胞术检测的细胞0、8、16和24小时凋亡率分别为(4.87±0.70)%、(27.27±2.00)%、(51.53±2.81)%及(60.5±3.20)%;vegf mRNA表达下调,而hif-1αmRNA表达无明显变化;HIF-1α蛋白、VEGF蛋白和BCL-2蛋白表达下调,而BAX和caspase-3蛋白表达上调,BAX/BCL-2比率升高并呈时间依赖性(r=0.973,p<0.01)。结论:3种白血病细胞株均显示hif-1α和vegf mRNA表达,YC-1可以抑制白血病细胞HIF-1α蛋白表达,进而下调VEGF,并通过上调BAX/BCL-2比率、caspase-3蛋白表达诱导细胞凋亡。 This study was purposed to investigate the effect of a hypoxia-inducible factorinhibitor (YC-1) on expression of hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF) as well as induction of aproptosis in leukemic cell lines. RT-PCR was used to determine the levels of HIF-1α mRNA and VEGF mRNA in K562 ,U937 and Jurkat cells. After treatment of U937 cell with 4 μmol/L YC-l, cell apoptosis was assayed by DAPI staining under fluorescent microscope and flow cytometry with Annexin V-FITC/PI staining; the expression levels of HIF-1α mRNA and VEGF mRNA were measured with RT-PCR; the expression levels of HIF-1α, VEGF, BAX, BCL-2 and caspase-3 proteins were measured by Western blot. The results showed that HIF-1α mRNA and VEGF mRNA were expressed in all three leukemia cell lines. After treatment of U937 cell with 4 μmol/L YC-1 for 0,8,16 and 24 hours, the changes of morphologic features of U937 cells could be observed under fluorescent microscope and the apoptotic rates significantly increased in time-dependent manner, they were (4.87 ± 0.70)%, (27.27 ± 2.00)%, (51.53 ± 2.81 ) and (60.5 ± 3.20) % respectively, the expression levels of VEGF mRNA reduced, while the expression levels of HIF-1α mRNA had no obviously changes. Furthermore, the expression of HIF-1α, VEGF and BCL-2 decreased, while the expression of BAX and caspase-3 increased, the ratio of BAX/BCL-2 increased in time-dependent manner ( r = 0. 973, p 〈0.01 ). It is concluded that HIF-1α mRNA and VEGF mRNA are all expressed in in K562, U937 and Jurkat cells, YC-1 has significant effect on down-regulating the protein expression of HIF-1α and VEGF, and induces the apoptosis in U937. The mechanism of apoptosis in leukemic cells may involve in up-regulating BAX/BCL-2 ratio and expression of protein caspase-3.
出处 《中国实验血液学杂志》 CAS CSCD 2010年第1期74-78,共5页 Journal of Experimental Hematology
基金 国家自然科学基金资助项目 编号39970832 30740062 高等学校博士学科点专项科研基金 编号20070286042
关键词 白血病 低氧诱导因子1-1α 血管内皮生长因子 细胞凋亡 YC-1 U937细胞 leukemia HIF-1α VEGF apoptosis YC-1 U937
  • 相关文献

参考文献21

  • 1Otrock ZK, Hatoum HA, Awada AH, et al. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives. Crit Rev Oncol Hematol,2009;70(2) :93 -102.
  • 2Das B, Yeger H, Tsuchida R, et al. A hypoxia-driven vascular endothelial growth factor/Fltl autocrine loop interacts with hypoxia- inducible factor-1 alpha through mitogen-activated protein kinase/ extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Cancer Res ,2005 ;65 ( 16 ) :7267 - 7275.
  • 3Podar K, Anderson KC. The pathophysiologic role of VEGF in hematologic malignancies : therapeutic implications. Blood, 2005 ; 105(4) :1383 - 1395.
  • 4Yeo EJ, Chun YS, Park JW. New anticancer strategies targeting HIF-1. Biochem Pharmacol,2004 ;68 (6) : 1061 - 1069.
  • 5Chung JG, Yang JS, Huang LJ, et al. Proteomic approach to studying the cytotoxicity of YC-I on U937 leukemia ceils and antileukemia activity in orthotopic model of leukemia mice. Proteomics ,2007 ;7 ( 18 ) : 3305 - 3317.
  • 6Clerici C, Planes C. Gene regulation in the adaptive process to hypoxia in lung epithelial ceils, Am J Physiol Lung Cell Mol Physiol,2009 ;296 ( 3 ) : 267 - 274.
  • 7Li WW, Hutnik M, Gehr G. Antiangiogenesis in haematological malignancies. Br J Haematol,2008 ; 143 (5) :622 - 631.
  • 8Wellmann S, Guschmann M, Griethe W, et al. Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF. Leukemia,2004 ; 18 ( 5 ) :926 - 933.
  • 9Lu L, Zhang L, Xiao Z, et al. Neuropilin-1 in acute myeloid leukemia: expression and role in proliferation and migration of leukemia cells. Leuk Lymphoma,2008 ;49(2) :331 -338.
  • 10刘学文,贺其图,李志琴,马宏杰,李静,贾国荣,卢艳,韩海燕,李喆,云雁,张冬霞.环氧化酶-2在白血病患者骨髓细胞中表达及与血管新生的关系[J].中国实验血液学杂志,2009,17(1):40-42. 被引量:14

二级参考文献20

  • 1徐喜慧,贺其图,贾国荣,宋芳,赵晓华,徐军.白血病患者骨髓血管新生的研究[J].白血病.淋巴瘤,2005,14(2):80-82. 被引量:9
  • 2许文林,沈慧玲,袁伟,王法春,江云伟.抗血管内皮生长因子发夹状核酶基因抑制白血病细胞裸鼠体内生长和肿瘤内血管生成[J].中华血液学杂志,2006,27(7):465-469. 被引量:2
  • 3Perez-Atayde AR, Sallan SE, Tedrow U, et al. Spectrum of tumor angiogeneses in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1997 ; 150: 815 - 821.
  • 4Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol, 1994; 87: 503 - 508.
  • 5Giles FJ, Kantarjian HM, Bekete BN, et al. Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukemia and are associated with reduced survival. Br J Haemotol, 2002; 119:38-45.
  • 6Liu XI-I, Kirschenbaum A, Yao S, et al. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis. 1999 ; 17:687 - 694.
  • 7Leahy KM, Omberge RL, Wang Y, et al. Cyclooxygenase-2 inhibitor by celecoxib reduces proliferation and apoptosis in angiogenic endothelial cells. Cancer Res, 2002 ; 62 : 625 - 631.
  • 8de Bont ES, Fidler V, Meeuwsen T, et al. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients. Clin Cancer Res,2002,8:2856-2861.
  • 9Verstovsek S, Lunin S, Kantarjian H, et al. Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia. Leuk Res,2003, 27:661-669.
  • 10Zogakis TG, Libutti SK. General aspects of anti-angiogenesis and cancer therapy. Expert Opin Biol Ther,2001,1:253-275.

共引文献18

同被引文献54

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部